Co-morbidities increase the risk of disability pension among MS patients: A population-based nationwide cohort study

BMC Neurology

Volumn 14, Issue 1, 2014, Pages

  Tinghög, Petter ^a   Björkenstam, Charlotte ^a   Carstensen, John ^b   Jansson, Catarina ^a   Glaser, Anna ^a   Hillert, Jan ^a   Alexanderson, Kristina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Co morbidity; Disability pension; Insurance medicine; Multiple sclerosis; Sick leave; Synergistic effects

Indexed keywords

PRESCRIPTION DRUG;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISABILITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; MENTAL DISEASE; MULTIPLE SCLEROSIS; MUSCULOSKELETAL DISEASE; PENSION; SWEDEN; COMPLICATION; ECONOMICS; EPIDEMIOLOGY; MIDDLE AGED; RURAL POPULATION; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; URBAN POPULATION; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; COMORBIDITY; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PENSIONS; RURAL POPULATION; SOCIOECONOMIC FACTORS; SWEDEN; TREATMENT OUTCOME; URBAN POPULATION; YOUNG ADULT;

EID: 84902303449     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-14-117     Document Type: Article

References (28)

1. Kobelt G, Berg J, Lindgren P, Fredrikson S, Jönsson B. Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosur Ps 2006, 77:918-926.
2. Tinghög P, Hillert J, Kjeldgård L, Wiberg M, Glaser A, Alexanderson K. High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study. Mult Scle J 2013, 19:1923-1930.
3. WHO World Report on Disability 2011, Geneva: WHO, WHO.
4. Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007, 17:210-218. 10.1111/j.1750-3639.2007.00064.x, 17388952.
5. Noseworthy JH. Progress in determining the causes and treatment of multiple sclerosis. Nature 1999, 399:A40-A47.
6. Marrie RA, Horwitz RI. Emerging effects of comorbidities on multiple sclerosis. Lancet Neurol 2010, 9:820-828. 10.1016/S1474-4422(10)70135-6, 20650403.
7. Marrie R, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 2010, 74:1041-1047. 10.1212/WNL.0b013e3181d6b125, 2848107, 20350978.
8. Turpin K, Carroll L, Cassidy J, Hader W. Deterioration in the health-related quality of life of persons with multiple sclerosis: the possible warning signs. Mult Scler 2007, 13:1038-1045. 10.1177/1352458507078393, 17895295.
9. Dallmeijer AJ, Beckerman H, de Groot V, van de Port IG, Lankhorst GJ, Dekker J. Long-term effect of comorbidity on the course of physical functioning in patients after stroke and with multiple sclerosis. J Rehabil Med 2009, 41:322-326. 10.2340/16501977-0335, 19363563.
10. Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology 2009, 72:117-124. 10.1212/01.wnl.0000333252.78173.5f, 2677495, 18971448.
11. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiat 2002, 159:1862-1868. 10.1176/appi.ajp.159.11.1862, 12411220.
12. Smith S, Young C. The role of affect on the perception of disability in multiple sclerosis. Clin Rehabil 2000, 14:50-54. 10.1191/026921500676724210, 10688344.
13. World Health Organization International statistical classification of diseases and related health problems 2004, Geneva, 2, 10th revision, World Health Organization.
14. Alexanderson K. Measuring health. Indicators for working women. Women's health at work 1998, Stockholm: National Institute for Working Life, AMK K, Bildt Thorbjörnsson C.
15. Statistics Sweden Rikets indelningar: årsbok över regionala indelningar med koder, postadresser, telefonnummer m m. 2003 [Country classifications: yearbook of regional classifications with codes, postal addresses, phone numbers etc. 2003] 2003, Stockholm, Statistics Sweden.
16. Rothman KJ, Greenland S, Lash TL. Modern epidemiology 2008, Philadelphia: Lippincott Williams & Wilkins.
17. Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005, 20:575-579. 10.1007/s10654-005-7835-x, 16119429.
18. Beiske A, Svensson E, Sandanger I, Czujko B, Pedersen E, Aarseth J, Myhr K. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 2008, 15:239-245. 10.1111/j.1468-1331.2007.02041.x, 18215155.
19. Patten SB, Svenson LW, Metz LM. Psychotic disorders in MS: population-based evidence of an association. Neurology 2005, 65:1123-1125. 10.1212/01.wnl.0000178998.95293.29, 16217073.
20. Gottberg K, Einarsson U, Fredrikson S, von Koch L, Holmqvist LW. A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: association with functioning and sense of coherence. J Neurol Neurosur Ps 2007, 78:60-65.
21. Janssens AC, Buljevac D, Van Doorn P, van der Meché FG, Polman C, Passchier J, Hintzen R. Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal study. Mult Scler 2006, 12:794-801. 10.1177/1352458506070935, 17263009.
22. Möller A, Wiedemann G, Rohde U, Backmund H, Sonntag A. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psych Scand 1994, 89:117-121.
23. Arnett P, Randolph J. Longitudinal course of depression symptoms in multiple sclerosis. J Neurol Neurosur Ps 2006, 77:606-610.
24. Figved N, Klevan G, Myhr KM, Glad S, Nyland H, Larsen JP, Harboe E, Omdal R, Aarsland D. Neuropsychiatric symptoms in patients with multiple sclerosis. Acta Psych Scand 2005, 112:463-468.
25. Gold SM, Irwin MR. Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Immunol Allergy Clin 2009, 29:309-320.
26. Jadidi E, Mohammadi M, Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler 2013, 19:1336-1340. 10.1177/1352458513475833, 23364857.
27. Kang JH, Chen YH, Lin HC. Comorbidities amongst patients with multiple sclerosis: a population-based controlled study. Eur J Neurol 2010, 17:1215-1219. 10.1111/j.1468-1331.2010.02971.x, 20192982.
28. Marrie R. The influence of comorbid diseases and health behaviors on clinical characteristics, disability at diagnosis, and disability progression in multiple sclerosis 2007, Cleavland, Ohio: Case Western Reserve University.